SynthesisBMC psychiatry2025
Prevalence and associated factors of depression among adult patients with epilepsy in Ethiopia: a systematic review and meta-analysis, 2025.
Synthesis in BMC psychiatry, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundEpilepsy is a major public health issue in Africa. Among individuals with epilepsy, the prevalence of depression is estimated to be two to three times higher than in the general population. The coexistence of epilepsy and depression has a detrimental impact on patients’ quality of life and increases the risk of anxiety disorders, substance use (including alcohol and drug dependence), suicide, poor medication adherence, and uncontrolled seizures.
objectivesTo conduct a systematic review and meta-analysis on the prevalence and associated factors of depression among adult patients with epilepsy in Ethiopia, 2025.
methodsA comprehensive literature search was performed across several databases, including PubMed, MEDLINE, the Cochrane Database of Systematic Reviews, UpToDate, EMBASE, and National Institute for Health and Care Excellence (NICE). The review focused on the prevalence of depression and its associated factors among patients with epilepsy. A random-effects model was applied to conduct pooled analysis, and the Joanna Briggs Institute quality appraisal checklist was used to evaluate the quality of included studies.
resultsA total of eleven studies (n = 4,027) were included in the final analysis. The pooled prevalence of depression among adult patients with epilepsy in Ethiopia was 43.26% (95% CI: 38.45%, 48.08%; I2 = 89.96%; p < 0.0001). Subgroup analysis indicated that the prevalence was 48.61% (95% CI: 44.92%–52.31%) in the Oromia region, and 38.28% (95% CI: 27.50%, 49.06%) in Addis Ababa. Poor adherence to anti-seizure medication 1.41 (95% CI: 1.17, 1.65), perceived stigma 1.74 (95% CI: 1.57, 1.91), and lower educational status 0.39 (95% CI: 0.26, 0.51) were significant predictors of depression among adult patients with epilepsy.
conclusionThe overall prevalence of depression among adult patients with epilepsy in Ethiopia remains high. Perceived stigma, low educational status, and poor adherence to anti-seizure medication were identified as key risk factors. Greater emphasis should be placed on reducing stigma and promoting adherence to ant-seizure medication to improve mental health outcomes in this population. CLINICAL
trial registrationNot applicable. CLINICAL TRIAL NUMBER: Not applicable.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.